Truscreen Share Issue

TRUSCREEN LIMITED
DIRECTOR’S CERTIFICATE
The following directors, having voted in favour of a resolution dated 12 July 2019 relating to the
issue of shares, hereby certify:

1. The terms of the issue are as follows:
Number of shares to be issued: 9,677,363
Issue price of shares: 10.6 cents per share
Persons to who shares to be issued: Eligible investors in a private placement
Payment date for consideration: On or before the date of the issue of the
Shares
Details of consideration: Cash

2. In our opinion, the consideration for and terms of issue are fair and reasonable to the
Company and all existing shareholders.



Anthony Ho Chris Horn


Robert Hunter Kelly Hickey


Ronald Jones Chris Lawrence

TRUSCREEN LIMITED
DIRECTOR’S CERTIFICATE
Section 49 of the Companies Act 1993
The following directors of Truscreen Limited, having voted in favour of a resolution dated the
12 day of July 2019 relating to the issue of options to acquire shares in the Company (“Options”),
hereby certify:

1. The terms of issue are as follows:
Number of Options to be issued: 9,677,363
Consideration for Options: The Options were issued as a free
attaching option to the share placement
and share issue dated 12 July 2019 on a
one for one basis.
Consideration payable on exercise of the
Options: 13 cents, payable in cash on the date of
exercise of each Option
Expiry date: The Options have an expiry date of 12 July
2021
2. In our opinion, the consideration for and terms of issue of the Options and the ordinary
shares to be issued upon their exercise, are fair and reasonable to the Company and to all
existing shareholders.
DATED the 12 day of July 2019


Anthony Ho Chris Horn


Robert Hunter Kelly Hickey


Ronald Jones Chris Lawrence

---

TRUSCREEN SHARE PLACEMENT
TRUSCREEN LIMITED (TRU)
Section 1: Issuer information
Name of issuer TRUSCREEN LIMITED
NZX ticker code TRU
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZTRUE0001S7
Currency NZ Dollars
Section 2: Capital change details – ORDINARY SHARES
Number issued/acquired/redeemed 9,677,363
Nominal value (if any) -
Issue/acquisition/redemption price per security $0.106
Nature of the payment (for example, cash or other consideration) Cash
Amount paid up (if not in full) $Paid in full
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of Financial
Products of the Class, excluding any Treasury Stock, in existence)
1

4.27%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion price and
Conversion date and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option (for example, the
exercise price and exercise date)
n/a
Reason for issue/acquisition/redemption and specific authority for
issue/acquisition/redemption/ (the reason for change must be
identified here)
Commercial expansion of the
business
Working capital
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury Stock)
and the total number of Financial Products of the Class held as
Treasury Stock after the issue/acquisition/redemption.
226,534,804 ordinary shares

In the case of an acquisition of shares, whether those shares are to
be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption, including
a reference to the rule pursuant to which the issue, acquisition, or
redemption is made
Director’s resolution dated 12 July
2019 and NZX Listing Rule 4.5
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
No restrictions
Date of issue/acquisition/redemption
2
12 July 2019

1
The percentage is calculated after issue
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).

Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Guy Robertson
Contact person for this announcement Guy Robertson
Contact phone number +61 2 407 983 270
Contact email address guyrobertson@truscreen.com
Date of release through MAP

12 July 2019

TRUSCREEN OPTION PLACEMENT
Section 1: Issuer information
Name of issuer TRUSCREEN LIMITED
NZX ticker code TRU
Class of financial product Unlisted Options
ISIN (If unknown, check on NZX website) NZTRUE0001S7
Currency NZ Dollars
Section 2: Capital change details – SHARE OPTIONS
Number issued/acquired/redeemed 9,677,363
Nominal value (if any) -
Issue/acquisition/redemption price per security Free attaching to share issue
Nature of the payment (for example, cash or other consideration) -
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of Financial
Products of the Class, excluding any Treasury Stock, in existence)
3

100%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion price and
Conversion date and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option (for example, the
exercise price and exercise date)
Unlisted options attaching to
shares on a one for one basis.
The options are exercisable at 13
cents per share with an expiry
date of 12 July 2021
Reason for issue/acquisition/redemption and specific authority for
issue/acquisition/redemption/ (the reason for change must be
identified here)
Free attaching options to share
issue on one for one basis
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury Stock)
and the total number of Financial Products of the Class held as
Treasury Stock after the issue/acquisition/redemption.
9,677,363 unlisted options

In the case of an acquisition of shares, whether those shares are to
be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption, including
a reference to the rule pursuant to which the issue, acquisition, or
redemption is made
Director’s resolution dated 12 July
2019 and NZX Listing Rule 4.5

3
The percentage is shown as after issue.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The options are exercisable at 13
cents per share with an expiry
date of 12 July 2021
Date of issue/acquisition/redemption
4
12 July 2019
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Guy Robertson
Contact person for this announcement Guy Robertson
Contact phone number +61 2 407 983 270
Contact email address guyrobertson@truscreen.com
Date of release through MAP

12 July 2019

About TruScreen:
Watch our video on TruScreen: http://truscreen.com/truscreen-the-company/truscreen-
ultra-video/
TruScreen is a Cervical Cancer Screening Device
which offers the latest technology in cervical
screening, providing real-time, accurate detection
of pre-cancerous and cancerous cervical cells to
help improve the health and well-being of women
around the world. TruScreen’s real-time cervical cancer
technology utilises a digital wand which is placed on the surface
of the cervix to measure electrical and optical signals from the
surrounding tissues. A sophisticated proprietary algorithm
framework is utilised to detect pre-cancerous change, or cervical
intraepithelial neoplasia (CIN), by optical and electrical measurement of cervical tissue.
TruScreen offers an alternative approach to cervical screening, resolving many of the
ongoing issues with Pap tests including failed samples, poor patient follow up, patient
discomfort and the need for supporting laboratory infrastructures. As such, TruScreen
target market is developing countries where no large scale cervical cancer screening
programs and infrastructure are in place, such as; China, Mexico, Africa, Russia and India.
TruScreen’s cervical cancer screening device is EC certified for use throughout Europe and
CFDA approved for sale in China. Truscreen gained recognition from Global NGO’s WHO and
Unitaid in a joint Cervical Cancer Technology Landscape released at the 72
nd
World Health
Assembly.
For more information, visit our website at www.truscreen.com


4
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).